Eastover Investment Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.95M | Buy |
37,449
+403
| +1% | +$74.8K | 3.12% | 19 |
|
|
2025
Q1 | $7.76M | Sell |
37,046
-329
| -0.9% | -$68.9K | 3.75% | 13 |
|
|
2024
Q4 | $6.64M | Sell |
37,375
-682
| -2% | -$121K | 3.11% | 18 |
|
|
2024
Q3 | $7.52M | Buy |
38,057
+1,183
| +3% | +$234K | 3.52% | 15 |
|
|
2024
Q2 | $6.12M | Buy |
36,874
+446
| +1% | +$74K | 2.93% | 15 |
|
|
2024
Q1 | $6.63M | Sell |
36,428
-515
| -1% | -$93.8K | 3.24% | 12 |
|
|
2023
Q4 | $5.73M | Buy |
36,943
+1,146
| +3% | +$178K | 3.03% | 20 |
|
|
2023
Q3 | $5.34M | Buy |
35,797
+664
| +2% | +$99K | 3.21% | 15 |
|
|
2023
Q2 | $4.73M | Sell |
35,133
-4,140
| -11% | -$558K | 2.53% | 24 |
|
|
2023
Q1 | $6.26M | Buy |
39,273
+277
| +0.7% | +$44.1K | 3.5% | 9 |
|
|
2022
Q4 | $6.3M | Buy |
38,996
+293
| +0.8% | +$47.4K | 3.61% | 8 |
|
|
2022
Q3 | $5.37M | Buy |
38,703
+418
| +1% | +$58K | 3.35% | 10 |
|
|
2022
Q2 | $5.86M | Sell |
38,285
-14,420
| -27% | -$2.21M | 3.58% | 9 |
|
|
2022
Q1 | $8.54M | Buy |
52,705
+3,845
| +8% | +$623K | 4.51% | 3 |
|
|
2021
Q4 | $6.62M | Buy |
48,860
+719
| +1% | +$97.4K | 3.82% | 5 |
|
|
2021
Q3 | $5.19M | Buy |
48,141
+565
| +1% | +$60.9K | 3.38% | 9 |
|
|
2021
Q2 | $5.36M | Buy |
47,576
+2,085
| +5% | +$235K | 3.48% | 8 |
|
|
2021
Q1 | $4.92M | Sell |
45,491
-3,151
| -6% | -$341K | 3.48% | 11 |
|
|
2020
Q4 | $5.21M | Sell |
48,642
-230
| -0.5% | -$24.6K | 3.61% | 7 |
|
|
2020
Q3 | $4.28M | Buy |
48,872
+755
| +2% | +$66.1K | 3.25% | 11 |
|
|
2020
Q2 | $4.72M | Buy |
48,117
+844
| +2% | +$82.9K | 3.9% | 5 |
|
|
2020
Q1 | $3.6M | Buy |
+47,273
| New | +$3.6M | 3.49% | 8 |
|